Luxcel Biosciences

Luxcel Biosciences develops and commercializes real-time, fluorescence-based, plate-reader-compatible assay kits for monitoring cell metabolism, mitochondrial function, drug safety, and toxicity in vitro. Its flagship MitoXpress® platform enables kinetic, real-time monitoring of oxygen consumption and cell metabolism using standard lab equipment, without the need for specialized instruments. The company's technologies are used by academic researchers and industrial partners for drug discovery, safety toxicology, and basic research. Luxcel was acquired by Agilent Technologies in January 2018 and continues to operate as a specialized group within Agilent, headquartered in Cork, Ireland, with ongoing R&D, manufacturing, and customer support activities[1][3][7].